Molnupiravir efficacy 2023

Available at: . Molnupiravir can accelerate the rehabilitation of COVID-19 patients, but it does not significantly reduce mortality and hospitalisation

2024-03-29
    Estradiol and progesterone therapy
  1. Our data suggest that the omicron sublineages BQ
  2. Published online 2023 May 5
  3. (D) RT-PCR negativity
  4. 1 and XBB
  5. Design Cohort study
  6. com
  7. 1 and XBB | NEJM (Dec 2022) BQ
  8. 0%), while the percentage of discontinuation was similar (0
  9. XBB
  10. 11% in molnupiravir vs
  11. Setting: US Department of Veterans Affairs
  12. Trial design and participants
  13. (D) RT
  14. 1
  15. 24 and 1
  16. Infection
  17. 77), and in patients with inadequate COVID-19 vaccination 0
  18. 1 and XBB | NEJM (Dec 2022) BQ
  19. 0%), while the percentage of discontinuation was similar (0
  20. As this is a new medicine, there is little safety data